On a special episode (first released on June 20, 2024) of The Excerpt podcast: With the advent of CRISPR as a gene editing technology, there are new opportunities to develop breakthrough treatments ...
A no-stress way to work with PDFs exists.
Beam Therapeutics develops precision genetic medicines using base editing technology to target serious inherited diseases.
Entrepreneurs say it’s time to safety-test designer baby technology. A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...
Qi Biodesign, a company involved in genome-editing technologies, announced that it has completed a $75 million funding round, which includes seed funding and Series Pre-A and Series A stages. Beijing ...
The concept of CRISPR gene-editing is still quite young. Although the discovery of CRISPRs themselves—repeating DNA sequences present in single-celled organisms, such as bacteria—can be traced back to ...
Jeff Bartel is chairman and managing director of Hamptons Group, a private investment and strategic advisory firm headquartered in Miami. Gene editing technology, a major biotechnology advance, is ...
For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old ...
CRISPR is being used in an experimental effort to eliminate the virus that causes AIDS. The gene-editing technology CRISPR has been used to change the genes of human babies, to modify animals, and to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results